Hartman Institute for Therapeutic Organ Regeneration

Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells.

TitleTransient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells.
Publication TypeJournal Article
Year of Publication2000
AuthorsMorrison SJ, Perez SE, Qiao Z, Verdi JM, Hicks C, Weinmaster G, Anderson DJ
JournalCell
Volume101
Issue5
Pagination499-510
Date Published2000 May 26
ISSN0092-8674
KeywordsAnimals, Avian Proteins, Bone Morphogenetic Protein 2, Bone Morphogenetic Proteins, Cell Differentiation, Cell Line, Transformed, Chick Embryo, Fibroblasts, Humans, Immunoglobulin Fc Fragments, Intracellular Signaling Peptides and Proteins, Membrane Proteins, Mice, Nerve Tissue Proteins, Neural Crest, Neuregulin-1, Neuroglia, Neurons, Receptors, Cell Surface, Receptors, Notch, Recombinant Fusion Proteins, Recombinant Proteins, Signal Transduction, Solubility, Stem Cells, Transforming Growth Factor beta
Abstract

The genesis of vertebrate peripheral ganglia poses the problem of how multipotent neural crest stem cells (NCSCs) can sequentially generate neurons and then glia in a local environment containing strong instructive neurogenic factors, such as BMP2. Here we show that Notch ligands, which are normally expressed on differentiating neuroblasts, can inhibit neurogenesis in NCSCs in a manner that is completely dominant to BMP2. Contrary to expectation, Notch activation did not maintain these stem cells in an uncommitted state or promote their self-renewal. Rather, even a transient activation of Notch was sufficient to cause a rapid and irreversible loss of neurogenic capacity accompanied by accelerated glial differentiation. These data suggest that Notch ligands expressed by neuroblasts may act positively to instruct a cell-heritable switch to gliogenesis in neighboring stem cells.

DOI10.1016/s0092-8674(00)80860-0
Alternate JournalCell
PubMed ID10850492
Grant ListR01 NS23476 / NS / NINDS NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065